Asset
FLORBETABEN F-18
Lantheus Holdings Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT06790394 | phase1 | recruiting | 2025-10-21 | 2026-09-01 | Lantheus Germany GmbH | Test-retest Study With [18F]FBB in Cardiac Amyloidosis |
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 204677 | NDA | LANTHEUS BIOSCIENCES LTD |
Marketed products (1)
- NEURACEQ